Jubilant Ingrevia Raises ₹1 Billion Through Commercial Paper Issuance
Jubilant Ingrevia, a leading specialty chemicals company, has successfully raised ₹1 billion (approximately $12.00 million) through the issuance of commercial papers. This short-term debt instrument is typically used for immediate funding needs with maturities up to one year. The move demonstrates Jubilant Ingrevia's proactive approach to managing short-term financing needs and its ability to access cost-effective funding sources.
14May 25
Jubilant Ingrevia Eyes Growth in Specialty Chemicals and Health Solutions
Jubilant Ingrevia announces strategic focus on specialty chemicals and nutrition and health solutions for future growth. The company plans to capitalize on increasing demand in these sectors, develop new products, and expand market presence. Additionally, Jubilant Ingrevia will implement cost management initiatives to streamline operations and improve profitability. While specific financial figures are not provided, management expresses confidence in sustained growth based on these strategic initiatives.
Jubilant Ingrevia reported a consolidated net profit of ₹74.05 crore in Q4 FY25, up 153.16% from ₹29.25 crore in Q4 FY24. Total income remained stable at ₹1,059.62 crore. For the full fiscal year 2025, the company posted a net profit of ₹251.17 crore and total income of ₹4,215.43 crore.
25Apr 25
Jubilant Ingrevia Advances in Renewable Energy Venture, Acquires Partial Stake in O2 Renewable Energy XVIII
Jubilant Ingrevia has acquired a partial stake in O2 Renewable Energy XVIII Private Limited, comprising 3,602,875 equity shares and 61,346 Compulsorily Convertible Debentures. This acquisition, part of a planned 28% stake, aims to access 6.41 MW of renewable power for its manufacturing facilities in Uttar Pradesh and Gujarat. The remaining stake acquisition is expected to be completed by June 2025. This move aligns with the company's sustainability goals and green energy requirements.